Glyburide Tablets
Intended to support blood sugar regulation, utilized to manage type 2 diabetes.
Strengths: 2.5 · 5mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Daonil
- Therapeutic class
Sulfonylurea
- Pharmacological class
Sulfonylurea Antidiabetic
- Minor side effects
hypoglycaemia; nausea; vomiting
- Moderate side effects
weight gain; visual disturbance; pruritus
- Dosage forms
Tablet
- Administration route
Oral use
- Patient summary
Intended to support blood sugar regulation, utilized to manage type 2 diabetes.
- Prescription status
POM
- Manufacturer
Sanofi
- Onset Time
1 hour
- Duration
24 hours
- Storage instructions
Store below 25°C in a dry place.
- Drug interactions
alcohol; cimetidine; warfarin
- Age restrictions
Adults only
- Pregnancy and breastfeeding
Pregnancy: Not recommended. Breastfeeding: Not recommended.
Contraindications
hypersensitivity to glyburide; type 1 diabetes; diabetic ketoacidosis; severe renal impairment; porphyria
Precautions and warnings
high risk of hypoglycaemia; carry sugar source; regular blood glucose monitoring necessary; avoid in elderly patients
Serious side effects
prolonged hypoglycaemia — requires immediate medical attention; liver cholestasis — requires immediate medical attention
Mechanism of action
Glyburide (glibenclamide) is a potent sulfonylurea that promotes insulin secretion by closing potassium channels in pancreatic beta cells. This mechanism effectively lowers plasma glucose levels in patients with type 2 diabetes.
Glyburide Tablets
Intended to support blood sugar regulation, utilized to manage type 2 diabetes.
Editorial Notes
- Active ingredient(s): Glibenclamide
- Listed indication(s): Type 2 Diabetes Mellitus
Usually available as
- 360 tablets - 2.5 mg1393-2-5-mg-16719
- 360 tablets - 5 mg1393-5-mg-16725